Minerva Neurosciences Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Due Diligence for Asset Managers
Analyze the public filings of asset managers
Dive into the EDGAR, IAPD, CAFR source data
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Minerva Neurosciences Inc
TickerNERV
CIK #0001598646
CUSIP603380205
SectorLife Sciences - Pharmaceutical Preparations
Address245 First Street Suite 1800, Cambridge, MA 02142
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Minerva Neurosciences Inc 2023-07-03 Exemption: 506(b) · Remaining: $19,999,994 · Duration: One year or less · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001598646] 10-K
[0001598646] 10-Q
[0001598646] 3
[0001598646] 4
[0001598646] 5
[0001598646] 8-K
[0001598646] D
[0001598646] SC 13D
[0001598646] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Janus Henderson Group PLC Minerva Neurosciences Inc [2026-05-15] 0.0
Coastlands Capital LP Minerva Neurosciences Inc [2026-02-20] 0.0
Logos Global Management LP Minerva Neurosciences Inc [2026-02-17] 0.0
Balyasny Asset Management LP Minerva Neurosciences Inc [2026-02-17] 0.0
Adage Capital Management LP Minerva Neurosciences Inc [2026-02-12] 0.0
Vivo Opportunity Fund Holdings LP Minerva Neurosciences Inc [2025-12-31] 0.0
Farallon Capital Partners LP Minerva Neurosciences Inc [2025-12-29] 0.0
Federated Hermes Inc Minerva Neurosciences Inc [2025-12-29] 0.0
Federated Hermes Inc Minerva Neurosciences Inc [2025-10-28] 0.0
FMR LLC Minerva Neurosciences Inc [2024-02-09] 0.0
Boehringer AG Minerva Neurosciences Inc [2023-07-07] 20.79
Point72 Asset Management LP Minerva Neurosciences Inc [2022-08-23] 8.8
Assenagon Asset Management Sa Minerva Neurosciences Inc [2021-11-24] 14.23
Assenagon Asset Management Sa Minerva Neurosciences Inc [2021-11-24] 3.24
Vanguard Group Inc Minerva Neurosciences Inc [2021-02-10] 9.96
Luthringer Remy Minerva Neurosciences Inc [2019-02-14] 5.9
BlackRock Inc Minerva Neurosciences Inc [2019-02-08] 6.3
BlackRock Inc Minerva Neurosciences Inc [2018-02-01] 5.2
Highland Capital Management Fund Advisors LP Minerva Neurosciences Inc [2016-02-11] 9.4
Federated Investors Inc /PA/ Minerva Neurosciences Inc [2015-04-09] 18.19
Cormorant Global Healthcare Master Fund LP Minerva Neurosciences Inc [2015-03-23] 7.2
FMR LLC Minerva Neurosciences Inc [2015-02-13] 0.0
Care Capital III LLC Minerva Neurosciences Inc [2014-07-18] 21.2
Index Venture Associates III Ltd Minerva Neurosciences Inc [2014-07-18] 15.4
Johnson & Johnson Minerva Neurosciences Inc [2014-07-17] 18.0
Luthringer Remy Minerva Neurosciences Inc [2014-07-17] 7.0
Form 3/4/5 Filer 2011 - 2026
Kupfer David
Minerva Neurosciences Inc
van Heek G Jan
Hasler Hans Peter
Kaul Inderjit
Ahlholm Frederick W
Luthringer Remy
Laghrissi-Thode Fouzia
O'Connor James Joseph
Race Geoff
Hilleman Jeryl L
Boehringer Ingelheim International GmbH
Boehringer AG
Barclays PLC
Doyle William F
Reilly Joseph H
Smith Devin Whittemore
Saoud Jay
Davidson Michael
Russell Richard E
Index Venture Associates IV Ltd
Yucca Jersey SLP
Index Venture Associates V Ltd
Index Venture Associates III Ltd
Beer Marc D
Johnson & Johnson
Johnson & Johnson Development Corp ET AL
Vandervelpen Nico
Levine Mark S
Ollier Michele
de Rubertis Francesco
Care Capital Offshore Investments III LP
Care Capital III LLC
Care Capital Investments III LP
Pellegrini Lorenzo
Vivaldi Coelho Rogerio
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Kaul Inderjit
Stock Option (right to buy) · derivative
2025-12-22 Grant 364,504 $0.00
Hasler Hans Peter
Stock Option (right to buy) · derivative
2025-12-22 Grant 50,000 $0.00
Kupfer David
Stock Option (right to buy) · derivative
2025-12-22 Grant 50,000 $0.00
Laghrissi-Thode Fouzia
Stock Option (right to buy) · derivative
2025-12-22 Grant 50,000 $0.00
van Heek G Jan
Stock Option (right to buy) · derivative
2025-12-22 Grant 50,000 $0.00
Ahlholm Frederick W
Employee Stock Option (right to buy) · derivative
2025-12-22 Grant 500,000 $0.00
Race Geoff
Employee Stock Option (right to buy) · derivative
2025-12-22 Grant 1,500,000 $0.00
Luthringer Remy
Employee Stock Option (right to buy) · derivative
2025-12-22 Grant 2,250,000 $0.00
Kaul Inderjit
Stock Option (right to buy) · derivative
2025-11-14 Grant 9,500 $0.00
van Heek G Jan
Stock Option (right to buy) · derivative
2024-12-05 Grant 12,500 $0.00
Laghrissi-Thode Fouzia
Stock Option (right to buy) · derivative
2024-12-05 Grant 12,500 $0.00
Kupfer David
Stock Option (right to buy) · derivative
2024-12-05 Grant 12,500 $0.00
Hasler Hans Peter
Stock Option (right to buy) · derivative
2024-12-05 Grant 12,500 $0.00
Ahlholm Frederick W
Employee Stock Option (right to buy) · derivative
2024-12-05 Grant 47,500 $0.00
Race Geoff
Employee Stock Option (right to buy) · derivative
2024-12-05 Grant 95,000 $0.00
Luthringer Remy
Employee Stock Option (right to buy) · derivative
2024-12-05 Grant 105,000 $0.00
Luthringer Remy
Employee Stock Option (right to buy) · derivative
2023-10-04 Grant 100,450 $0.00
Race Geoff
Employee Stock Option (right to buy) · derivative
2023-10-04 Grant 87,050 $0.00
Ahlholm Frederick W
Employee Stock Option (right to buy) · derivative
2023-10-04 Grant 42,850 $0.00
van Heek G Jan
Stock Option (right to buy) · derivative
2023-09-27 Grant 12,500 $0.00
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 47 38,298,188
2025-12-31 33 23,072,824
2025-09-30 25 1,979,787
2025-06-30 23 1,944,682
2025-03-31 23 1,952,081
2024-12-31 24 2,085,909
2024-09-30 23 2,118,041
2024-06-30 22 2,086,314
2024-03-31 22 2,121,296
2023-12-31 21 2,421,780
2023-09-30 21 2,403,063
2023-06-30 20 2,352,312
Form 13F Holdings
Firm Period DFND Voting Shares
Y-Intercept Hong Kong Ltd [2026-06-30] SOLE 64,687 64,687
Apella Capital LLC [2026-06-30] SOLE 0 42,250
Fortitude Family Office LLC [2026-06-30] SOLE 303 303
Farther Finance Advisors LLC [2026-06-30] SOLE 0 100
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com